Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

NCT02947815 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharospasm

Interventions

DRUG: Clostridium Botulinum Toxin Type A
DRUG: Clostridium Botulinum Toxin Type A

Sponsor

Daewoong Pharmaceutical Co. LTD.